ACS Report Shows Prostate Cancer on the Rise, Cervical Cancer on the Decline
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Many thyroid cancer survivors said they lacked understanding of their treatment before receiving it.
The highest risk of thyroid cancer was seen in patients with both high genetic risk and an unfavorable lifestyle.
Cabozantinib prolongs progression-free survival in patients with previously treated radioiodine-refractory differentiated thyroid cancer, a phase 3 trial suggests.
Proton FLASH radiotherapy is feasible, safe, and provides pain relief for cancer patients with bone metastases, according to a first-in-human trial.
A retrospective evaluation of lab results linked the likelihood of certain cancer types with the presence of specific pathogenic variants in CHEK2.
Active surveillance may be a viable management strategy for most diagnosed thyroid cancers, according to researchers.
Donafenib demonstrated efficacy in patients with progressive, locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
Many thyroid cancers are discovered in patients who undergo surgery without thyroid-referable symptoms, an international study suggests.
There were more than 18 million cancer survivors in the United States at the beginning of this year, according to new data.